WilliamTHuMDPhD, FAAN
Neurology • New Brunswick, NJNeuroimaging, Neurodegenerative, Dementia & Geriatrics
Associate Professor and Chief of Cognitive Neurology, Rutgers-Robert Wood Johnson Medical School, Institute for Health, Health Care and Aging Research, Rutgers Biomedical and Health Sciences
Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson St
Ste 6100
New Brunswick, NJ 08901Phone+1 732-235-7340
Summary
- Dr. William Hu is a neurologist in New Brunswick, NJ and is affiliated with Robert Wood Johnson University Hospital. He received his medical degree from Mayo Clinic College of Medicine and Science and has been in practice 13 years. He also speaks multiple languages, including Chinese (Mandarin). He specializes in neuroimaging, neurodegenerative, and dementia & geriatrics and is experienced in movement disorders, alzheimer's disease, cognitive disorders, and geriatrics / dementia. He has more than 100 publications and over 500 citings.
Education & Training
Georgia Institute of TechnologyN/A, Bioinformatics, 2013
Penn MedicinePost-Doctoral Fellowship, 2008 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2005 - 2008- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2004 - 2005
- Mayo Clinic College of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2024 - Present
NJ State Medical License 2020 - 2025
GA State Medical License 2010 - 2021
AL State Medical License 2020 - 2020
PA State Medical License 2008 - 2010
MN State Medical License 2005 - 2009- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialitiesBehavioral Neurology and Neuropsychiatry
Awards, Honors, & Recognition
- Paul B Beeson Career Development Award in Aging Research National Institute of Aging/American Federation of Aging Research, 2013
Clinical Trials
- Effects of Atomoxetine in Mild Cognitive Impairment Start of enrollment: 2012 Mar 01
- Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) Start of enrollment: 2013 May 01
- African American Alzheimer's Progression Markers - CSF and Neuro-Imaging Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.Lianne M Reus, Iris E Jansen, Betty M Tijms, Pieter Jelle Visser, Niccoló Tesi
Brain. 2024-10-03 - Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high-risk cohort of middle-aged adults.Maria Misiura, Chinkuli Munkombwe, Kay Igwe, Danielle D Verble, Kelly D S Likos
Alzheimer's & Dementia. 2024-09-01 - Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia.Yanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, Emma L van der Ende, Sterre C M de Boer
Medrxiv. 2024-08-20
Press Mentions
Doctors Say This Common Injury Could Be a Dementia Warning SignOctober 12th, 2024- After He Got Lost Driving Home, Doctors Told Him He Had Sleep Apnea. It Was Alzheimer’sFebruary 7th, 2023
- A Newly Recognized Dementia Called LATE Can Account for 40% of Older PeopleJuly 13th, 2022
- Join now to see all
Professional Memberships
- Member
- American Neurological AssociationMember
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
